Latest News

4
Feb

Biofortuna supports World Cancer Day

We are proud to support the UICC’s World Cancer Day initiative

20
Jan

Biofortuna shortlisted for 2020 Bionow awards.

We are delighted to share the news that we have been shortlisted for the 2020 BioNow awards.

10
Dec

Biofortuna sets a new production record.

Biofortuna sees record production levels across November and December

12
Jun

Biofortuna appointed as CMO for QuantuMDx CE–marked assay

Biofortuna has provided assay development and manufacturing support to QuantuMDx Group Limited to assist in the manufacturing scale-up, regulatory approval and launch of their rapid, sensitive SARS-CoV-2 test.

18
Mar

Coronavirus Update from Biofortuna

In light of the current situation with COVID-19, we would like to take this opportunity to assure you that plans have been put into place to ensure business continuity at Biofortuna.

25
Jul

Biofortuna unveils ampDRY™ air-dried master mix

Biofortuna (Liverpool, UK) – the international IVD contract research and contract manufacturing company – will be launching ampDRY™, its patent pending stabilised master mix for PCR applications, at the AACC Annual Scientific Meeting and Clinical Lab Expo in Chicago, July 29 to August 2. ampDRY hotstart master mix has been developed to enable complete end-stage or real-time PCR assays to

Read more